|
2025
|
P/S
|
Demonstration of goods; Import-export agency services; Business services, namely, combined strate... |
|
|
P/S
|
Medicinal preparations for the treatment of infectious diseases and for use in oncology; Vaccines... |
|
2024
|
Invention
|
Use of dr-18 and m1 virus in preparation of anti-tumor drug. The present disclosure belongs to th... |
|
|
Invention
|
Use of dr-18 and herpes simplex virus in preparation of antitumor drug. The present invention rel... |
|
2023
|
Invention
|
Use of dr-18 and oncolytic vaccinia virus in preparation of anti-tumor drug. The present disclosu... |
|
|
P/S
|
Medicines for human purposes for the treatment of cancer; medicinal drinks; pharmaceutical prepar... |
|
|
P/S
|
Medicines for human purposes; medicinal drinks;
pharmaceutical preparations; injectable pharmace... |
|
2020
|
Invention
|
Phenothiazines and their derivatives for use as a medicament.
Disclosed is a new use of a phenot... |
|
|
Invention
|
Novel application of phenothiazines or compound having similar structure in pharmaceutics. A nove... |
|
|
Invention
|
M1 virus mutant and use thereof.
Provided is an M1 virus. Further provided are a series of uses ... |
|
|
Invention
|
M1 virus mutant and use thereof. Provided is an M1 virus. Further provided are a series of uses o... |
|
2019
|
Invention
|
Use of alphavirus in preparation of antitumor drugs. Disclosed is use of alphavirus in preparatio... |
|
|
Invention
|
Use of proteasome inhibitor and alphavirus in preparation of anti-tumor medicament.
Use of a pro... |
|
|
Invention
|
Use of proteasome inhibitor and alphavirus in preparation of anti-tumor medicament. Use of a prot... |
|
2018
|
Invention
|
Use of mevalonate metabolic pathway inhibitor and alphavirus in preparing anti-tumor drug.
Discl... |
|
|
Invention
|
Use of aurora kinase inhibitor and alphavirus in preparing anti-tumor drug. Disclosed is the use ... |
|
|
Invention
|
Use of mevalonate metabolic pathway inhibitor and alphavirus in preparing anti-tumor drug. Disclo... |
|
|
Invention
|
Application of cdk inhibitor and oncolytic virus in preparation of antitumor drug. An application... |
|
|
Invention
|
Use of parp inhibitor and oncolytic virus in preparing anti-tumor drug. Disclosed is the use of a... |
|
|
Invention
|
Application of e3 ligase inhibitor and oncolytic virus in preparing anti-tumor drug. An applicati... |
|
2017
|
Invention
|
Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drug.
This invention bel... |
|
|
Invention
|
Use of vcp inhibitor and oncolytic virus in the preparation of an anti-tumor drug. The present in... |
|
|
Invention
|
Use of vcp inhibitor and oncolytic virus in the preparation of an anti-tumor drug. Use of VCP (va... |
|
|
Invention
|
Use of iap inhibitor and oncolytic virus in preparation of anti-tumor drug. Described herein is u... |
|
|
Invention
|
Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drug. The use of Bcl-xL i... |
|
2016
|
Invention
|
Combined application of direct or indirect agonist of epac and oncolytic virus. Disclosed are a p... |
|
|
Invention
|
Application of chrysophanol or its derivatives and oncolytic virus in preparing anti-tumor drugs.... |
